Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.364NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.364NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.364NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.364NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.364NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.177.67NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.177.67NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.177.67NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.177.67NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
B.1.177.67NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.177.67NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
B.1.177.67NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17944.4US
B.1.177.67NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.177.67NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.177.67NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.177.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.67NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.67NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.177.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.67NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.67NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.67NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.177.67NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.177.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16604.2China
B.1.177.67NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.67NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.277NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1936.12China
B.1.277NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
B.1.277NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-1125.12Thailand
B.1.277NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-2479.67Thailand
B.1.277NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.277NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-1638.08US
B.1.277NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-4348.25US
B.1.277NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1269.64US
B.1.277NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F92.4864US
B.1.277NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-4850.89US
B.1.277NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-1711.48Singapore
B.1.277NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.277NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-748.712Germany
B.1.277NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-2353.5Germany
B.1.277NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-211.894South Korea
B.1.277NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.277NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-2834.99Japan
B.1.277NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-389.525Hong Kong
AY.28 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21977.3China
AY.28 (Delta)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
AY.28 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used